Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
EXT2 Gene Exostoses, multiple, type 2 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
EXT2 Gene Seizures, scoliosis, and macrocephaly syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
EXT2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
PathGroup United States | 73 | 505 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Congenital Disorders of Glycosylation Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 141 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Multiple exostoses Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Multiple exostoses Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Exostoses, multiple, type 2, 133701, Autosomal dominant (Multiple osteochondromas) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.